Frusemide
Frusemide is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
66.7%
2 of 3 finished
33.3%
1 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Decongestion Guided By VExUS Score Or Lung Ultrasound For Renal Recovery In Patients With Cardiorenal Syndrome Type -1
Diuretic Efficacy of Aminophylline and Furosemide Combination vs Furosemide Alone in Critically Ill Adults
SGLT2 Inhibition in Combination With Diuretics in Heart Failure
Effects of Aminophylline on Renal Function and Urine Volume of AKI Patient
Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone.
Clinical Trials (6)
Decongestion Guided By VExUS Score Or Lung Ultrasound For Renal Recovery In Patients With Cardiorenal Syndrome Type -1
Diuretic Efficacy of Aminophylline and Furosemide Combination vs Furosemide Alone in Critically Ill Adults
SGLT2 Inhibition in Combination With Diuretics in Heart Failure
Effects of Aminophylline on Renal Function and Urine Volume of AKI Patient
Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone.
Frusemide Infusion for the Prevention of Deterioration in Renal Function Post Cardiac Surgery.
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6